28 April 2021
Ideagen PLC
("Ideagen," "the Company" or the "Group'')
Director Dealings and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that the following executive directors of the Company; David Hornsby and Ben Dorks have purchased 3 Ordinary Shares within the SIP as part of the automatic re-investment of dividends received on their Ordinary Shares held in the SIP. These directors now have the following beneficial interests in the share capital of the Company.
| Executive Director | Previous shareholding | New shareholding | % of issued share capital held |
| David Hornsby | 7,636,546 | 7,636,549 | 3.0% |
| Ben Dorks | 2,653,213 | 2,653,216 | 1.0% |
Alan Carroll, a non-executive director, has also purchased 58 Ordinary Shares on 11 December 2020 at a price of 229.5 pence each and 52 Ordinary Shares on 13 April 2021 at a price of 289p each. Both acquisitions arose as a result of the automatic reinvestment of the Company's recent dividends by his nominated broker.
Following the above acquisitions, Mr Carroll's beneficial interest has increased to 204,421 shares representing approximately 0.1% of the Company's issued ordinary share capital.
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.
Enquiries:
| Ideagen plc | 01629 699100 |
| David Hornsby, Executive Chairman | |
| Ben Dorks, Chief Executive Officer | |
| Emma Hayes, Chief Finance Officer | |
| | |
| finnCap Limited | 020 7220 0500 |
| Henrik Persson/James Thompson (Nomad) | |
| Alice Lane (ECM)
| |
| Canaccord Genuity | 020 7523 8000 |
| Simon Bridges | |
| Richard Andrews | |
About Ideagen plc
Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).
A global supplier of regulatory and compliance solutions, Ideagen provides a common software platform and an integrated risk-based approach to meet multi-industry standards, enabling compliance with relevant laws, policies, and regulations.
The Group provides software and services to organisations operating within highly regulated industries such as life sciences, healthcare, banking and finance, insurance, aviation, and aerospace and defence, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.
Currently, more than 5,700 organisations use Ideagen's products including nine of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.
Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 250 hospitals across the UK and US amongst its client base. For further information please visit www.ideagen.com .
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | David Hornsby | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Executive Chairman | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ideagen plc | ||||
| b) | LEI | 213800KS1MLITOVNYC85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
| Identification code | GB00B0CM0C50 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: · Aggregated volume · Price |
3 ordinary shares of 1p each purchased at 280p per share | ||||
| e) | Date of the transaction | 17 March 2021 | ||||
| f) | Place of the transaction | Off market | ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Ben Dorks | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | CEO | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ideagen plc | ||||
| b) | LEI | 213800KS1MLITOVNYC85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
| Identification code | GB00B0CM0C50 | |||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: · Aggregated volume · Price |
3 ordinary shares of 1p each purchased at 280p per share | ||||
| e) | Date of the transaction | 17 March 2021 | ||||
| f) | Place of the transaction | Off market | ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Alan Carroll | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Non-executive Director | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ideagen PLC | ||||
| b) | LEI | 213800KS1MLITOVNYC85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
| Identification code | GB00B0CM0C50 | |||||
| b) | Nature of the transaction | Purchase of additional shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: · Aggregated volume · Price | Automatic reinvestment of dividend into 58 ordinary shares at a price of 229.5p.
| ||||
| e) | Date of the transaction | 11 December 2020 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM market (XLON) | ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Alan Carroll | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Non-executive Director | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ideagen PLC | ||||
| b) | LEI | 213800KS1MLITOVNYC85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
| Identification code | GB00B0CM0C50 | |||||
| b) | Nature of the transaction | Purchase of additional shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information: · Aggregated volume · Price | Automatic reinvestment of dividend into 52 ordinary shares at a price of 289p.
| ||||
| e) | Date of the transaction | 13 April 2021 | ||||
| f) | Place of the transaction | London Stock Exchange, AIM market (XLON) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
